Search results for "BIOFILM"

showing 10 items of 394 documents

Bacteria associated with periodontal disease are also increased in health.

2020

Background The objective of this cross-sectional clinical study was to analyze the differences in the microbiome in gingival sulci of adult patients in the presence or absence of chronic periodontitis. Material and Methods Patients with or without periodontal disease were included in this cross-sectional study. Subgingival biofilm samples were collected and analyzed by 16S massive pyrosequencing. Functional analyses were also performed. Results A total of 15 phyla, 154 genera and 351 species were detected globally. Differences between disease and non-disease samples were observed in all taxonomical levels which suggest functional profile changes in the community. It was found that the main …

AdultCross-sectional studyGingivaPhysiologyDiseaseTranscriptome03 medical and health sciences0302 clinical medicinemedicineHumansPeriodontologyMicrobiomeGeneral DentistrybiologyBacteriaResearchMicrobiotaBiofilm030206 dentistrymedicine.diseasebiology.organism_classification:CIENCIAS MÉDICAS [UNESCO]Chronic periodontitisCross-Sectional StudiesOtorhinolaryngologyBiofilmsUNESCO::CIENCIAS MÉDICASChronic PeriodontitisPyrosequencingSurgeryBacteria
researchProduct

Phenotypic and genetic analysis of biofilm formation by Staphylococcus epidermidis.

2012

Objective. The most important virulence factor of Staphylococcus epidermidis is their capability to form a biofilm on the surfaces of implanted medical devices. The accumulative phase of biofilm formation is linked to the production of intercellular adhesin encoded by the icaADBC operon and accumulation-associated protein by the aap gene. The aim of the study was to investigate biofilm formation phenotypically and genetically in clinical strains of S. epidermidis in comparison with commensal strains. Material and Methods. The study was carried out in 4 hospitals in Riga, Latvia. In total, 105 clinical strains of Staphylococcus epidermidis isolated from patients’ blood (n=67) and intravenous…

AdultMaleOperonVirulenceVirulence factorlaw.inventionMicrobiologylawStaphylococcus epidermidisOperonStaphylococcus epidermidisMedicineHumansPolymerase chain reactionAgedAged 80 and overCross InfectionbiologyVirulencebusiness.industryBiofilmGeneral MedicineMiddle AgedStaphylococcal Infectionsbiology.organism_classificationmedicine.diseaseBacterial adhesin<em>Staphylococcus epidermidis</em>; nosocomial infections; biofilm formation; virulence factorsGenes BacterialBacteremiaBiofilmsFemalebusinessMedicina (Kaunas, Lithuania)
researchProduct

Reactivation of aerobic granular sludge for the treatment of industrial shipboard slop wastewater: Effects of long-term storage on granules structure…

2021

Abstract This work reports on reactivation of aerobic granular sludge (AGS) for the treatment of industrial recalcitrant wastewater (slop wastewater) characterized by high salinity and hydrocarbons. AGS were reactivated in two reactors, R1 and R2, to treat industrial slop wastewater after a long-term storage for 12-months at 4 °C. In R1, salt-adapted mature aerobic granules were previously subjected to a step-wise increase of hydrocarbons, whereas in R2 aerobic granules were previously cultivated in presence of salinity and hydrocarbons. After a short-term reactivation period, the slop dosage caused a simultaneous decrease of granules dimensions and proteins/polysaccharides (PN/PS) ratio do…

Aerobic granular sludge reactivationNGS 16S rDNA02 engineering and technology010501 environmental sciences01 natural sciencesIndustrial wastewater treatmentGranulationIndustrial wastewater020401 chemical engineering0204 chemical engineeringSafety Risk Reliability and QualityTPH hydrocarbonWaste Management and Disposal0105 earth and related environmental sciencesbiologyChemistryProcess Chemistry and TechnologyBiofilmBiodegradationPulp and paper industrybiology.organism_classificationSalinityWastewaterMicrobial population biologyEPSBacteriaBiotechnology
researchProduct

Anaerobic moving bed biofilm reactor followed by aerobic granular sludge for brewery wastewater treatment

2018

Small and medium breweries discharging to municipal sewers without treatment generate significant loads with typical concentrations reported by Valta et al. (2014) as 2-6 g COD L-1, 25-80 mg TN L-1, 10-50 mg TP L-1, with pH between 4.5 and 12. Treatment of the high-strength wastewater requires specialized low footprint processes, such as aerobic granular sludge (AGS), capable of high-rate degradation, as well as simultaneous nitrogen and phosphorous removal (Wang et al., 2007). The objective of this study was to evaluate the start-up period of AGS receiving brewery wastewater after initial anaerobic pre-treatment.

Anaerobic moving bed biofilm reactorSettore ICAR/03 - Ingegneria Sanitaria-AmbientaleAerobic granular sludge
researchProduct

Antimicrobial activity of biogenically produced spherical Se-nanomaterials embedded in organic material against Pseudomonas aeruginosa and Staphyloco…

2017

In an effort to prevent the formation of pathogenic biofilms on hydroxyapatite (HA)-based clinical devices and surfaces, we present a study evaluating the antimicrobial efficacy of Spherical biogenic Se-Nanostructures Embedded in Organic material (Bio Se-NEMO-S) produced by Bacillus mycoides SelTE01 in comparison with two different chemical selenium nanoparticle (SeNP) classes. These nanomaterials have been studied as potential antimicrobials for eradication of established HA-grown biofilms, for preventing biofilm formation on HA-coated surfaces and for inhibition of planktonic cell growth of Pseudomonas aeruginosa NCTC 12934 and Staphylococcus aureus ATCC 25923. Bio Se-NEMO resulted more e…

Anti-Infective Agent0301 basic medicineStaphylococcus aureusMetal Nanoparticleschemistry.chemical_elementBacillusBiocompatible MaterialsBioengineeringBacillus02 engineering and technologymedicine.disease_causeApplied Microbiology and BiotechnologyBiochemistrybiofilmantimicrobialsNanomaterialsMicrobiologyHydroxyapatiteSelenium03 medical and health sciencesAnti-Infective AgentsBiogenic Selenium nanoparticles (SeNPs) Hydroxyapatite Bacillus biofilm antimicrobials green synthesisOrganometallic CompoundsEnvironmental MicrobiologymedicineResearch ArticlesBiocompatible MaterialOrganometallic CompoundbiologyPseudomonas aeruginosagreen synthesisBiofilmBacillus mycoides021001 nanoscience & nanotechnologybiology.organism_classificationAntimicrobialBacilluDurapatite030104 developmental biologychemistryStaphylococcus aureusBiofilmsPseudomonas aeruginosaStaphylococcus aureu0210 nano-technologySeleniumResearch ArticleBiotechnologyBiogenic Selenium nanoparticles (SeNPs)
researchProduct

Development of a new indole derivative dry powder for inhalation for the treatment of biofilm-associated lung infections

2022

The aim of this work was to produce an inhalable dry powder formulation of a new anti-biofilm compound (SC38). For this purpose, chitosan was used as a polymeric carrier and l-leucine as a dispersibility enhancer. SC38 was entrapped by spray-drying into previously optimized chitosan microparticles. The final formulation was fully characterized in vitro in terms of particle morphology, particle size and distribution, flowability, aerodynamic properties, anti-biofilm activity and effects on lung cell viability. The SC38-loaded chitosan microparticles exhibited favorable aerodynamic properties with emitted and respirable fractions higher than 80 % and 45 % respectively. The optimized formulati…

Anti-biofilmChitosanLeucineCell viability studySpray-dryingPharmaceutical ScienceDesign of experiments
researchProduct

Echinoderm Antimicrobial Peptides: The Ancient Arms of the Deuterostome Innate Immune System

2016

Antimicrobial peptides (AMPs) are widely expressed in organisms and have been linked to innate and acquired immunity in vertebrates. These compounds are constitutively expressed from different cellular types to interact directly with infectious agents and/or modulate immunoreactions. In invertebrates, including echinoderms, which lack a vertebrate-type adaptive immune system, AMPs represent the major humoral defense system against infection, showing a diverse spectrum of action mechanisms, most of them related to plasma membrane disturbance and lethal alteration of microbial integrity. Here, we summarize the knowledge of AMPs in echinoderms as Strongylocins identified in the sea urchins, St…

Antibiofilm peptideInnate immunityEchinodermImmunology and Microbiology (all)BiofilmMedicine (all)Settore BIO/05 - ZoologiaAntimicrobial peptideSettore BIO/19 - Microbiologia Generale
researchProduct

FRAGMENTS OF BETA-THYMOSIN FROM THE SEA-URCHIN PARACENTROTUS LIVIDUS AS NOVEL ANTIMICROBIAL PEPTIDES AGAINST STAPHYLOCOCCAL BIOFILMS

2012

With the aim to face the threat of pathogen biofilms intrinsically resistant to conventional antibiotics, we focused on coelomocytes, the immune mediators in echinoderms, as source of novel antimicrobial peptides (AMPs). The proteic fraction <5kDa from coelomocytes cytosol of the sea-urchin Paracentrotus lividus (5-CC) was tested against a group of Gram positive and Gram negative pathogen reference strains. The 5-CC of P. lividus resulted active against all tested strains at concentrations ranging from 15.8 to 253.7 mg/mL. The ability to prevent staphylococcal biofilm formation was evaluated against the biofilm of clinical strain S.epidermidis 1457 using live/dead staining in combination wi…

Antibiotic resistanceBiofilmAntimicrobial peptidesSettore BIO/19 - Microbiologia GeneraleStaphylococci
researchProduct

Bacterial metal nanoparticles to develop new weapons against bacterial biofilms and infections

2021

The widespread use of antibiotics has resulted in the outbreak and spread of antibiotic-resistant pathogens. Bacterial antibiotic resistance may develop at cellular and community levels. In the latter case, it is based on tolerance which implicates the shift from a free-living form of life (i.e., planktonic) to a sessile multi-stratified community (i.e., biofilm). Metal nanoparticles (MNPs) have been shown to be promising candidates as antimicrobial agents. MNPs are able to interact with and penetrate bacterial biofilms, thus, resulting effective antibiofilm compounds. Another interesting aspect is the possibility of using plants, fungi, yeasts, and bacteria to obtain biogenic MNPs (BMNP). …

Antibiotic resistancemedicine.drug_classAntibioticsMetal NanoparticlesMicrobial Sensitivity TestsApplied Microbiology and BiotechnologyMicrobiologyGreen synthesis03 medical and health sciencesAntibiotic resistanceDrug Resistance BacterialmedicineHumansMetal nanoparticles030304 developmental biology0303 health sciencesBacteriabiology030306 microbiologyChemistryBiofilmBacterial InfectionsGeneral MedicineAntimicrobialbiology.organism_classificationAnti-Bacterial AgentsAntibiofilm activityBiofilmsState of artBiogenic metal nanoparticlesEffluxBacteriaBiotechnologyApplied Microbiology and Biotechnology
researchProduct

Synthetic small molecules as anti-biofilm agents in the struggle against antibiotic resistance

2018

Abstract Biofilm formation significantly contributes to microbial survival in hostile environments and it is currently considered a key virulence factor for pathogens responsible for serious chronic infections. In the last decade many efforts have been made to identify new agents able to modulate bacterial biofilm life cycle, and many compounds have shown interesting activities in inhibiting biofilm formation or in dispersing pre-formed biofilms. However, only a few of these compounds were tested using in vivo models for their clinical significance. Contrary to conventional antibiotics, most of the anti-biofilm compounds act as anti-virulence agents as they do not affect bacterial growth. I…

Antibiotic resistancemedicine.drug_classAntibioticsMicrobial Sensitivity TestsBacterial growthDispersal agent01 natural sciencesVirulence factorMicrobiologySmall Molecule LibrariesStructure-Activity Relationship03 medical and health sciencesAntibiotic resistanceSmall Molecule LibrarieAnti-Bacterial AgentDrug Discoverymedicine030304 developmental biologyPharmacology0303 health sciencesBacteriaDose-Response Relationship DrugMolecular StructureMicrobial Sensitivity Test010405 organic chemistryChemistryBiofilmOrganic ChemistryBiofilmDrug Resistance MicrobialGeneral Medicinebiochemical phenomena metabolism and nutritionAnti-biofilm agentSettore CHIM/08 - Chimica FarmaceuticaSmall moleculeAnti-Bacterial Agents0104 chemical sciencesAnti-adhesion agentBiofilmsAnti-virulence compoundAnti biofilmEuropean Journal of Medicinal Chemistry
researchProduct